ASHPOfficial

This podcast will provide members with an update on federal and state action on the 340B program. We’ll talk through 340B policy shifts at the federal level and what’s happening in the states. We’ll also discuss what we’re watching as 340B cases make their way through the courts. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Wendy St. Peter and Dr. Katie Cardone discuss the AJHP theme issue on the management of chronic kidney disease with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers share practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists are pivotal in disease prevention and health promotion by advocating and administering immunizations. Despite increased access of vaccines which can prevent diseases, complications, and death, many adults in the US are not up to date on their immunizations. The Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices provide annual guidance on vaccine recommendations. This podcast will cover 2025 vaccine updates for pneumococcal, respiratory syncytial virus (RSV), Hepatitis B, and Monkeypox virus (Mpox) with ASHP ambulatory care pharmacists highlighting personal perspectives and tips from their varied practice sites.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from Department of Veterans Affairs discusses their award winning submission to the ASHP Best Practices.  They will share how their utilized a Clinical Pharmacist Practitioner model to improve access to medication for opioid use disorder and provided care to patients where they prefer to be treated. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, three clinical specialists discuss success stories, best practices, and strategies for motivating learners.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Mr. Jean-Philippe Adam, Dr. Mélodie Richard-Laferrière, and Dr. Félix Trudel-Bourgault discuss the AJHP Practice Research Report, “Teleworking by hospital pharmacists: Another step to achieve decarbonization of the healthcare system,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A new ad hoc committee created as a collaboration between the Sections of Specialty Pharmacy Practitioners, Section of Pharmacy Practice Leaders, Section of Ambulatory Care Practitioners and Section of Inpatient Care Practitioners, the Infusion Services Strategy Committee began its work in August of 2024. Committee Chair, Samantha Bochenek, and Vice Chair, Noah Franz, join us on this podcast onsite at the ASHP Midyear Clinical Meeting to share some of their experiences within health system infusion services and an overview of the Committee’s goals and priority areas. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drug shortages remain a persistent threat to patient care and pharmacy operations, with 270 active shortages recorded in early 2025. In this episode of Hot Topics in Pharmacy, ASHP’s Mike Ganio hosts Erin Fox and April Giles to unpack the latest data, explore the day-to-day realities health systems are facing, and examine the complex challenges shaping the future of medication access. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.